On this page
The review in brief
YourEra gives a plausible starting point for an injectable-program comparison because route and recurring headline are visible. It still needs a pharmacy-specific label and clear renewal, cancellation and refund terms. Ask what follow-up would look like if no worthwhile change occurs. The presence of check-ins should be evaluated as care access, rather than proof of benefit from the peptide.
Open the provider record
- Published price
- $229/month displayed
- Product description
- Semax subcutaneous injection; exact dispensed package not established
- Access
- Online clinical assessment
In the published record
- Subcutaneous route and monthly headline are explicit
- Check-ins and messaging are described as included
Questions still open
- Actual package and pharmacy need confirmation
- Screening and state limitations apply
The route is explicit
YourEra’s Semax section describes a subcutaneous preparation and displays $229 per month. It also says check-ins and care messaging are included. That is more specific than a menu entry that names only the molecule, but still does not establish the exact dispensed package or a final individualized quote.
A monthly plan needs a refill description
Ask how much medication is supplied, when renewal occurs and whether a change in the clinician’s recommendation changes the charge. The number of days in a billing cycle is not automatically the number of days a vial remains usable. The dispensing label, rather than a marketing image, must resolve handling and beyond-use questions.
Screening remains a real condition
YourEra qualifies availability by state and clinical screening and says its vial images are illustrative. Those limits should stay attached to the offer. A visible start button is not an assurance that every adult with a focus complaint will receive this prescription or that every pharmacy serves every state.
Focus advice is not an efficacy test
The site connects the product with attention and mood. Setting a goal may make a discussion more concrete, but it does not eliminate placebo effects, sleep changes or day-to-day variation. Our healthy-volunteer imaging review explains why objective-looking measures also need a demonstrated connection to a meaningful functional outcome.
A useful price contrast
The Elevation Health review describes a package price whose route remains unresolved. Comparing those two numbers as monthly equivalents would hide the most important difference in the evidence available. First obtain a route-matched, package-specific proposal; then compare included care and financial commitments.
How we would assess the proposal
YourEra gives a plausible starting point for an injectable-program comparison because route and recurring headline are visible. It still needs a pharmacy-specific label and clear renewal, cancellation and refund terms. Ask what follow-up would look like if no worthwhile change occurs. The presence of check-ins should be evaluated as care access, rather than proof of benefit from the peptide.
Evidence index
Original research and documented service details.
- YourEra official Semax informationCompany website